Serum alkaline phosphatase, body composition, and risk of metabolic syndrome in middle-aged Korean
Some papers have suggested that alkaline phosphatase (ALP) level is a predictor of the metabolic syndrome (MetS) in the general population. However, the association is still controversial, and the mechanisms underlying an association between ALP level and the MetS have not been elucidated. We analyz...
Saved in:
Published in | ENDOCRINE JOURNAL Vol. 60; no. 3; pp. 321 - 328 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
The Japan Endocrine Society
2013
|
Subjects | |
Online Access | Get full text |
ISSN | 0918-8959 1348-4540 1348-4540 |
DOI | 10.1507/endocrj.EJ12-0331 |
Cover
Abstract | Some papers have suggested that alkaline phosphatase (ALP) level is a predictor of the metabolic syndrome (MetS) in the general population. However, the association is still controversial, and the mechanisms underlying an association between ALP level and the MetS have not been elucidated. We analyzed the association between serum ALP level and the development of the MetS over a 4-year period. A total of 14,224 subjects who visited the Health Promotion Center for a medical examination in 2005 were followed up after 4 years. Serum ALP level correlated positively with body fat mass and visceral fat mass. The adjusted geometric mean ALP levels were higher in subjects with elevated C-reactive protein level or greater fat mass (P < 0.001). None of the subjects had the MetS at baseline, but 1,179 exhibited the MetS at the 4-year follow-up. After multiple adjustments, the odds ratio (OR) was substantially higher for development of the MetS (OR 1.56, 95% confidence intervals, 1.21-2.01) in subjects in the highest ALP quintile compared with those in the lowest quintile. After adjusting for various covariates, we found significant associations between the quintile of serum ALP level and abdominal obesity, low high-density lipoprotein cholesterol level, and high triglyceride level. Higher serum ALP level was a significant predictor of the MetS in middle-aged Koreans. Serum ALP level correlated positively with body fat mass and independently with a more atherogenic lipid profile in the general population in Korea. |
---|---|
AbstractList | Some papers have suggested that alkaline phosphatase (ALP) level is a predictor of the metabolic syndrome (MetS) in the general population. However, the association is still controversial, and the mechanisms underlying an association between ALP level and the MetS have not been elucidated. We analyzed the association between serum ALP level and the development of the MetS over a 4-year period. A total of 14,224 subjects who visited the Health Promotion Center for a medical examination in 2005 were followed up after 4 years. Serum ALP level correlated positively with body fat mass and visceral fat mass. The adjusted geometric mean ALP levels were higher in subjects with elevated C-reactive protein level or greater fat mass (P < 0.001). None of the subjects had the MetS at baseline, but 1,179 exhibited the MetS at the 4-year follow-up. After multiple adjustments, the odds ratio (OR) was substantially higher for development of the MetS (OR 1.56, 95% confidence intervals, 1.21-2.01) in subjects in the highest ALP quintile compared with those in the lowest quintile. After adjusting for various covariates, we found significant associations between the quintile of serum ALP level and abdominal obesity, low high-density lipoprotein cholesterol level, and high triglyceride level. Higher serum ALP level was a significant predictor of the MetS in middle-aged Koreans. Serum ALP level correlated positively with body fat mass and independently with a more atherogenic lipid profile in the general population in Korea. Some papers have suggested that alkaline phosphatase (ALP) level is a predictor of the metabolic syndrome (MetS) in the general population. However, the association is still controversial, and the mechanisms underlying an association between ALP level and the MetS have not been elucidated. We analyzed the association between serum ALP level and the development of the MetS over a 4-year period. A total of 14,224 subjects who visited the Health Promotion Center for a medical examination in 2005 were followed up after 4 years. Serum ALP level correlated positively with body fat mass and visceral fat mass. The adjusted geometric mean ALP levels were higher in subjects with elevated C-reactive protein level or greater fat mass (P < 0.001). None of the subjects had the MetS at baseline, but 1,179 exhibited the MetS at the 4-year follow-up. After multiple adjustments, the odds ratio (OR) was substantially higher for development of the MetS (OR 1.56, 95% confidence intervals, 1.21-2.01) in subjects in the highest ALP quintile compared with those in the lowest quintile. After adjusting for various covariates, we found significant associations between the quintile of serum ALP level and abdominal obesity, low high-density lipoprotein cholesterol level, and high triglyceride level. Higher serum ALP level was a significant predictor of the MetS in middle-aged Koreans. Serum ALP level correlated positively with body fat mass and independently with a more atherogenic lipid profile in the general population in Korea.Some papers have suggested that alkaline phosphatase (ALP) level is a predictor of the metabolic syndrome (MetS) in the general population. However, the association is still controversial, and the mechanisms underlying an association between ALP level and the MetS have not been elucidated. We analyzed the association between serum ALP level and the development of the MetS over a 4-year period. A total of 14,224 subjects who visited the Health Promotion Center for a medical examination in 2005 were followed up after 4 years. Serum ALP level correlated positively with body fat mass and visceral fat mass. The adjusted geometric mean ALP levels were higher in subjects with elevated C-reactive protein level or greater fat mass (P < 0.001). None of the subjects had the MetS at baseline, but 1,179 exhibited the MetS at the 4-year follow-up. After multiple adjustments, the odds ratio (OR) was substantially higher for development of the MetS (OR 1.56, 95% confidence intervals, 1.21-2.01) in subjects in the highest ALP quintile compared with those in the lowest quintile. After adjusting for various covariates, we found significant associations between the quintile of serum ALP level and abdominal obesity, low high-density lipoprotein cholesterol level, and high triglyceride level. Higher serum ALP level was a significant predictor of the MetS in middle-aged Koreans. Serum ALP level correlated positively with body fat mass and independently with a more atherogenic lipid profile in the general population in Korea. |
Author | Kang, Moo Il Baek, Ki Hyun Park, Cheol Young Oh, Ki Won Kim, Mee Kyoung Park, Se Eun Rhee, Eun-Jung Lee, Won Young |
Author_xml | – sequence: 1 fullname: Oh, Ki Won organization: Department of Internal Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea – sequence: 1 fullname: Lee, Won Young organization: Department of Internal Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea – sequence: 1 fullname: Kang, Moo Il organization: Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea – sequence: 1 fullname: Kim, Mee Kyoung organization: Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea – sequence: 1 fullname: Park, Se Eun organization: Department of Internal Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea – sequence: 1 fullname: Rhee, Eun-Jung organization: Department of Internal Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea – sequence: 1 fullname: Park, Cheol Young organization: Department of Internal Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea – sequence: 1 fullname: Baek, Ki Hyun organization: Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23149655$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1v1DAQhi1URLeFH8AF-cihKf5OckRVKYVKHICz5TizrLeOndrJYf89DrukEgcuM5fnnRk9c4HOQgyA0FtKrqkk9QcIfbRpf337hbKKcE5foA3loqmEFOQMbUhLm6ppZXuOLnLek4JIwV-hc8apaJWUG9R9hzQP2PhH410APO5iHndmMhmucBf7A7ZxGGN2k4vhCpvQ4-TyI45bPMBkuuidxfkQ-hQHwC7gwfW9h8r8gh5_jQlMeI1ebo3P8ObUL9HPT7c_bj5XD9_u7m8-PlRWKT5VirBOMUEbZSS3rTTSCDCCSt4SW3eC27qxlAlLailVK6HpFABpupbZDijnl-j9ce6Y4tMMedKDyxa8NwHinDXljLO6kZwW9N0JnbsBej0mN5h00H-9FIAeAZtizgm2K0KJXtzrk3u9uNeL-5Kp_8lYN5nF25SM8_9N3h2T5RZnjY9h-YXexzmFYkzbJ_UnpBmhXBOiyidLa0ua0aU0jBDZNuR50j5P5QXr1SZNznpYdyui-VLWG1bC7kwqGP8Nq_W63g |
CitedBy_id | crossref_primary_10_1016_j_jceh_2023_101343 crossref_primary_10_1371_journal_pone_0133884 crossref_primary_10_1111_eci_13560 crossref_primary_10_1111_nep_12956 crossref_primary_10_1139_cjpp_2017_0579 crossref_primary_10_1155_2021_2365399 crossref_primary_10_3390_biom11060882 crossref_primary_10_1186_s12891_025_08408_2 crossref_primary_10_3390_metabo11050276 crossref_primary_10_1097_j_pbj_0000000000000228 crossref_primary_10_3390_nu14122442 crossref_primary_10_1016_j_cca_2019_10_015 crossref_primary_10_1371_journal_pone_0122921 crossref_primary_10_3389_fmed_2021_657957 crossref_primary_10_4093_dmj_2018_42_1_19 crossref_primary_10_1053_j_jrn_2019_10_004 crossref_primary_10_1016_j_bbagen_2015_09_014 crossref_primary_10_1016_j_ebiom_2015_11_027 crossref_primary_10_1371_journal_pone_0119752 crossref_primary_10_3390_ijerph10115523 crossref_primary_10_1080_00365513_2019_1585567 crossref_primary_10_1080_17474124_2017_1283984 crossref_primary_10_4103_1011_4564_167708 |
Cites_doi | 10.1161/CIRCULATIONAHA.109.851873 10.2337/diabetes.54.11.3140 10.1053/j.ackd.2011.01.001 10.1681/ASN.2008010014 10.1210/jc.2011-2280 10.2215/CJN.01560309 10.1038/ki.2008.248 10.1161/01.ATV.0000148324.63685.6a 10.1007/s00198-010-1504-y 10.1136/bmj.292.6512.13 10.1007/BF00280883 10.1038/ki.2008.26 10.1093/ndt/gfq144 10.1309/9N346GXX67B6PX5W 10.1161/ATVBAHA.110.214619 10.1161/CIRCULATIONAHA.105.169404 10.1016/j.amjmed.2010.11.030 10.1258/000456306776865179 10.1111/j.1600-6143.2009.02876.x 10.1212/WNL.0b013e3181ff966a 10.2337/diacare.27.6.1427 10.1016/j.ab.2006.04.028 |
ContentType | Journal Article |
Copyright | The Japan Endocrine Society |
Copyright_xml | – notice: The Japan Endocrine Society |
CorporateAuthor | The Catholic University of Korea Sungkyunkwan University School of Medicine Department of Internal Medicine |
CorporateAuthor_xml | – name: The Catholic University of Korea – name: Sungkyunkwan University School of Medicine – name: Department of Internal Medicine |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1507/endocrj.EJ12-0331 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1348-4540 |
EndPage | 328 |
ExternalDocumentID | 23149655 10_1507_endocrj_EJ12_0331 cq6endoc_2013_006003_009_0321_03282005980 article_endocrj_60_3_60_EJ12_0331_article_char_en |
Genre | Journal Article |
GroupedDBID | --- .55 .GJ 29G 2WC 3O- 53G 5GY 5RE AAEJM AAFWJ ACPRK ADBBV AENEX AFPKN AJJEV ALMA_UNASSIGNED_HOLDINGS BAWUL BKOMP CS3 DIK DU5 E3Z EBD EBS EJD EMOBN F5P GROUPED_DOAJ JMI JSF JSH KQ8 MOJWN OK1 OVT P2P RJT RNS RPM RZJ SV3 TKC TR2 X7M XSB ZGI ZXP AAYXX CITATION ACRZS CGR CUY CVF ECM EIF M~E NPM 7X8 |
ID | FETCH-LOGICAL-c663t-602b624186a53c95a5a4ea415390c7b43c78c124c0755695e8b6ee08b92cbe133 |
ISSN | 0918-8959 1348-4540 |
IngestDate | Thu Jul 10 22:58:39 EDT 2025 Wed Feb 19 02:35:02 EST 2025 Thu Apr 24 23:03:49 EDT 2025 Tue Jul 01 01:17:23 EDT 2025 Thu Jul 10 16:15:11 EDT 2025 Wed Sep 03 06:30:14 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c663t-602b624186a53c95a5a4ea415390c7b43c78c124c0755695e8b6ee08b92cbe133 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/endocrj/60/3/60_EJ12-0331/_article/-char/en |
PMID | 23149655 |
PQID | 1323278531 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1323278531 pubmed_primary_23149655 crossref_primary_10_1507_endocrj_EJ12_0331 crossref_citationtrail_10_1507_endocrj_EJ12_0331 medicalonline_journals_cq6endoc_2013_006003_009_0321_03282005980 jstage_primary_article_endocrj_60_3_60_EJ12_0331_article_char_en |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-00-00 |
PublicationDateYYYYMMDD | 2013-01-01 |
PublicationDate_xml | – year: 2013 text: 2013-00-00 |
PublicationDecade | 2010 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan |
PublicationTitle | ENDOCRINE JOURNAL |
PublicationTitleAlternate | Endocr J |
PublicationYear | 2013 |
Publisher | The Japan Endocrine Society |
Publisher_xml | – name: The Japan Endocrine Society |
References | 17. Mirza MA, Alsiö J, Hammarstedt A, Erben RG, Michaëlsson K, et al. (2011) Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals. Arterioscler Thromb Vasc Biol 31: 219-227. 2. Tonelli M, Curhan G, Pfeffer M, Sacks F, Thadhani R, Melamed ML, et al. (2009) Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation 120: 1784-1792. 15. Ali AT, Penny CB, Paiker JE, Psaras G, Ikram F, et al. (2006) The effect of alkaline phosphatase inhibitors on intracellular lipid accumulation in preadipocytes isolated from human mammary tissue. Ann Clin Biochem 43: 207-213. 7. Kerner A, Avizohar O, Sella R, Bartha P, Zinder O, et al. (2005) Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arterioscler Thromb Vasc Biol 25: 193-197. 10. Bae SJ, Choe JW, Chung YE, Kim BJ, Lee SH, et al. (2011) The association between serum osteocalcin levels and metabolic syndrome in Koreans. Osteoporos Int 22: 2837-2846. 8. Nakanishi N, Suzuki K, Tatara K (2004) Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 27: 1427-1432. 14. Ali AT, Penny CB, Paiker JE, Psaras G, Ikram F, et al. (2006) The relationship between alkaline phosphatase activity and intracellular lipid accumulation in murine 3T3-L1 cells and human preadipocytes. Anal Biochem 354: 247-254. 6. Blayney MJ, Pisoni RL, Bragg-Gresham JL, Bommer J, Piera L, et al. (2008) High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death. Kidney Int 74: 655-663. 22. Grethen E, Hill KM, Jones R, Cacucci BM, Gupta CE, et al. (2012) Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. J Clin Endocrinol Metab 97:1655-1662. 9. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D’Agostino RB Jr, et al. (2005) Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 54: 3140-3147. 21. Ali AT, Paiker JE, Crowther NJ. (2006) The relationship between anthropometry and serum concentrations of alkaline phosphatase isoenzymes, liver-enzymes, albumin, and bilirubin. Am J Clin Pathol 126:437-442. 12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. 4. Ryu WS, Lee SH, Kim CK, Kim BJ, Yoon BW (2010) Increased serum alkaline phosphatase as a predictor of long-term mortality after stroke. Neurology 75: 1995-2002. 3. Krishnamurthy VR, Baird BC, Wei G, Greene T, Raphael K, et al. (2011) Associations of serum alkaline phosphatase with metabolic syndrome and mortality. Am J Med 124: 566.e1-7. 19. Regidor DL, Kovesdy CP, Mehrotra R, Rambod M, Jing J, et al. (2008) Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol 19: 2193-2203. 5. Beddhu S, Ma X, Baird B, Cheung AK, Greene T (2009) Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease. Clin J Am Soc Nephrol 4: 1805-1810. 20. Zelle DM, Corpeleijn E, van Ree RM, Stolk RP, van der Veer E, et al. (2010) Markers of the hepatic component of the metabolic syndrome as predictors of mortality in renal transplant recipients. Am J Transplant 10: 106-114. 18. Kovesdy CP, Ureche V, Lu JL, Kalantar-Zadeh K (2010) Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD. Nephrol Dial Transplant 25: 3003-3011. 1. Lomashvili KA, Garg P, Narisawa S, Millan JL, O’Neill WC (2008) Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification. Kidney Int 73: 1024-1030. 13. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al.; American Heart Association; National Heart, Lung, and Blood Institute (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752. 11. Saverymuttu SH, Joseph AE, Maxwell JD (1986) Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J(Clin Res Ed) 292: 13-15. 16. Hruska KA, Mathew S (2011) The roles of the skeleton and phosphorus in the CKD mineral bone disorder. Adv Chronic Kidney Dis 18: 98-104. 11 22 12 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 10 21 |
References_xml | – reference: 4. Ryu WS, Lee SH, Kim CK, Kim BJ, Yoon BW (2010) Increased serum alkaline phosphatase as a predictor of long-term mortality after stroke. Neurology 75: 1995-2002. – reference: 15. Ali AT, Penny CB, Paiker JE, Psaras G, Ikram F, et al. (2006) The effect of alkaline phosphatase inhibitors on intracellular lipid accumulation in preadipocytes isolated from human mammary tissue. Ann Clin Biochem 43: 207-213. – reference: 2. Tonelli M, Curhan G, Pfeffer M, Sacks F, Thadhani R, Melamed ML, et al. (2009) Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation 120: 1784-1792. – reference: 9. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D’Agostino RB Jr, et al. (2005) Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 54: 3140-3147. – reference: 22. Grethen E, Hill KM, Jones R, Cacucci BM, Gupta CE, et al. (2012) Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. J Clin Endocrinol Metab 97:1655-1662. – reference: 21. Ali AT, Paiker JE, Crowther NJ. (2006) The relationship between anthropometry and serum concentrations of alkaline phosphatase isoenzymes, liver-enzymes, albumin, and bilirubin. Am J Clin Pathol 126:437-442. – reference: 1. Lomashvili KA, Garg P, Narisawa S, Millan JL, O’Neill WC (2008) Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification. Kidney Int 73: 1024-1030. – reference: 5. Beddhu S, Ma X, Baird B, Cheung AK, Greene T (2009) Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease. Clin J Am Soc Nephrol 4: 1805-1810. – reference: 12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. – reference: 19. Regidor DL, Kovesdy CP, Mehrotra R, Rambod M, Jing J, et al. (2008) Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol 19: 2193-2203. – reference: 13. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al.; American Heart Association; National Heart, Lung, and Blood Institute (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752. – reference: 16. Hruska KA, Mathew S (2011) The roles of the skeleton and phosphorus in the CKD mineral bone disorder. Adv Chronic Kidney Dis 18: 98-104. – reference: 3. Krishnamurthy VR, Baird BC, Wei G, Greene T, Raphael K, et al. (2011) Associations of serum alkaline phosphatase with metabolic syndrome and mortality. Am J Med 124: 566.e1-7. – reference: 10. Bae SJ, Choe JW, Chung YE, Kim BJ, Lee SH, et al. (2011) The association between serum osteocalcin levels and metabolic syndrome in Koreans. Osteoporos Int 22: 2837-2846. – reference: 8. Nakanishi N, Suzuki K, Tatara K (2004) Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 27: 1427-1432. – reference: 6. Blayney MJ, Pisoni RL, Bragg-Gresham JL, Bommer J, Piera L, et al. (2008) High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death. Kidney Int 74: 655-663. – reference: 11. Saverymuttu SH, Joseph AE, Maxwell JD (1986) Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J(Clin Res Ed) 292: 13-15. – reference: 14. Ali AT, Penny CB, Paiker JE, Psaras G, Ikram F, et al. (2006) The relationship between alkaline phosphatase activity and intracellular lipid accumulation in murine 3T3-L1 cells and human preadipocytes. Anal Biochem 354: 247-254. – reference: 17. Mirza MA, Alsiö J, Hammarstedt A, Erben RG, Michaëlsson K, et al. (2011) Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals. Arterioscler Thromb Vasc Biol 31: 219-227. – reference: 20. Zelle DM, Corpeleijn E, van Ree RM, Stolk RP, van der Veer E, et al. (2010) Markers of the hepatic component of the metabolic syndrome as predictors of mortality in renal transplant recipients. Am J Transplant 10: 106-114. – reference: 7. Kerner A, Avizohar O, Sella R, Bartha P, Zinder O, et al. (2005) Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arterioscler Thromb Vasc Biol 25: 193-197. – reference: 18. Kovesdy CP, Ureche V, Lu JL, Kalantar-Zadeh K (2010) Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD. Nephrol Dial Transplant 25: 3003-3011. – ident: 2 doi: 10.1161/CIRCULATIONAHA.109.851873 – ident: 9 doi: 10.2337/diabetes.54.11.3140 – ident: 16 doi: 10.1053/j.ackd.2011.01.001 – ident: 19 doi: 10.1681/ASN.2008010014 – ident: 22 doi: 10.1210/jc.2011-2280 – ident: 5 doi: 10.2215/CJN.01560309 – ident: 6 doi: 10.1038/ki.2008.248 – ident: 7 doi: 10.1161/01.ATV.0000148324.63685.6a – ident: 10 doi: 10.1007/s00198-010-1504-y – ident: 11 doi: 10.1136/bmj.292.6512.13 – ident: 12 doi: 10.1007/BF00280883 – ident: 1 doi: 10.1038/ki.2008.26 – ident: 18 doi: 10.1093/ndt/gfq144 – ident: 21 doi: 10.1309/9N346GXX67B6PX5W – ident: 17 doi: 10.1161/ATVBAHA.110.214619 – ident: 13 doi: 10.1161/CIRCULATIONAHA.105.169404 – ident: 3 doi: 10.1016/j.amjmed.2010.11.030 – ident: 15 doi: 10.1258/000456306776865179 – ident: 20 doi: 10.1111/j.1600-6143.2009.02876.x – ident: 4 doi: 10.1212/WNL.0b013e3181ff966a – ident: 8 doi: 10.2337/diacare.27.6.1427 – ident: 14 doi: 10.1016/j.ab.2006.04.028 |
SSID | ssj0033543 ssib022572652 ssib044735826 ssib058492669 ssib002822051 ssib000750009 |
Score | 2.115218 |
Snippet | Some papers have suggested that alkaline phosphatase (ALP) level is a predictor of the metabolic syndrome (MetS) in the general population. However, the... |
SourceID | proquest pubmed crossref medicalonline jstage |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 321 |
SubjectTerms | Adipose Tissue Adult Alanine Transaminase - blood Alkaline phosphatase Alkaline Phosphatase - blood Aspartate Aminotransferases - blood Body Composition C-Reactive Protein - analysis Cholesterol, LDL - blood Female Humans Inflammation Intra-Abdominal Fat Liver - enzymology Male Metabolic syndrome Metabolic Syndrome - epidemiology Middle Aged Obesity - enzymology Obesity, Abdominal - enzymology Republic of Korea - epidemiology Risk Factors Triglycerides - blood |
Title | Serum alkaline phosphatase, body composition, and risk of metabolic syndrome in middle-aged Korean |
URI | https://www.jstage.jst.go.jp/article/endocrj/60/3/60_EJ12-0331/_article/-char/en http://mol.medicalonline.jp/en/journal/download?GoodsID=cq6endoc/2013/006003/009&name=0321-0328e https://www.ncbi.nlm.nih.gov/pubmed/23149655 https://www.proquest.com/docview/1323278531 |
Volume | 60 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Endocrine Journal, 2013, Vol.60(3), pp.321-328 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGQAgJIb4pXzIST2QZSRzn4w2EisqqIhCbtLcodhxtY00KTR_KX8CfzZ3teCljiPHiVpFzcnI_X-7O90HIyyipmJRZ7vMgUH4c1jE6mphfx7yMqpKD_YZ-yNnHZHIQ7x3yw62tn4OopVUnduWPP-aV_A9X4RrwFbNkL8FZRxQuwH_gL4zAYRj_icew0TG2-PRrqZXFxVG7XByVXWmaJYq2WuuQcRuX1Qdq9tHkc9UBArDIdV-2AJ0fc-2x8EHMVN60BZWy2XDeN1UrMWHQGy6wdF2ZZ0p50zVKkDMXqdICd3rsTdarszN_66eeta33wVH5ZCO3vyhvbOdaj4RJJe2dimHmZ7mt8a2MSGXosuSmKFMvc00PAYstNhCgzORL228xM4nj58Q815EdSj_yye54D8NL-syvjZLav33qXAAimj5ApLAkCiRRIIkr5GqUpiEGh04_u_MoxriJv-yfz56PA4nX51axoeFcOwElH6s33JybgzdTAOVie0brNfu3yS1rkNC3Bl13yJZq7pLrMxtycY8IDTLag4wOQLZDEWJ0ALEdCgCjCDDa1tQBjPYAo8cNHQCMGoDdJwfvx_vvJr5tzOFLUFA7PwkikYDqlyUlZzLnJS9jVYIqyPJApiJmMs0kKI4S9FGe5FxlIlEqyEQeSaFCxh6Q7aZt1CNC6xoL6uVVxbiKq1QIEWmrWco6yFmSjUjQv8xC2qr12DzltLiQhSPyyt2yMCVb_jb5jeGQm2p3s5uaBAXDwd3iZmBeJEwDEhu8LewGXBbyW6KpFLhLCix9FOBPDmSiEIcMfbp5FozIix4OBYh3PLMrG9WulkXIwORJQaeGlT40OHErBdMMuz3wx5d54CfkRqQ7uqAX8SnZ7r6v1DPQqzvxXEP-F9uYzdA |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+alkaline+phosphatase%2C+body+composition%2C+and+risk+of+metabolic+syndrome+in+middle-aged+Korean&rft.jtitle=Endocrine+journal&rft.au=Kim%2C+Mee+Kyoung&rft.au=Baek%2C+Ki+Hyun&rft.au=Kang%2C+Moo+Il&rft.au=Park%2C+Se+Eun&rft.date=2013&rft.issn=0918-8959&rft.eissn=1348-4540&rft.volume=60&rft.issue=3&rft.spage=321&rft.epage=328&rft_id=info:doi/10.1507%2Fendocrj.EJ12-0331&rft.externalDBID=n%2Fa&rft.externalDocID=10_1507_endocrj_EJ12_0331 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0918-8959&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0918-8959&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0918-8959&client=summon |